1. CTNI-16. FEASIBILITY PILOT STUDY OF OKN-007 IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE CHEMORADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. (9th November 2020) Authors: Battiste, James; Sung, Sarah; Wright, Deborah; Glenn, Chad; Algan, Ozer; Teague, April; Zhao, Yan; Cohoon, Andrew; Kim, Hyun Sook; Towner, Rheal Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTNI-35. UPDATE ON THE FEASIBILITY STUDY OF OKN-007 IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION IN NEWLY DIAGNOSED GLIOBLASTOMA. (12th November 2021) Authors: Battiste, James; Wright, Deborah; Glenn, Chad; Dunn, Ian; Algan, Ozer; Gunter, Tyler; Zhao, Daniel; Cohoon, Andrew; Sung, Sarah; Towner, Rheal; Kim, Hyon sook Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTNI-39. PHASE 1B CLINICAL TRIAL OF OKN-007 IN RECURRENT MALIGNANT GLIOMA. (9th November 2020) Authors: Battiste, James; Ikeguchi, Alexandra; Woo, Sukyung; Sharan, Satish; Zhao, Yan; Cohoon, Andrew; Sung, Sarah; Wright, Deborah; Teague, April; Jensen, Randy; Kim, Eun Ha; Yang, Won; Towner, Rheal Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP341/#510 Exploratory results of a phase IB trial of paclitaxel and carboplatin + galunisertib in patients with uterine and ovarian carcinosarcoma. (4th December 2022) Authors: Washington, Christina; Gunderson-Jackson, Camille; Walker, Joan; Mannel, Robert; Holman, Laura; Richardson, Debra; Neelakantan, Deepika; Cohoon, Andrew; Bhattacharya, Resham; Ding, Kai; Dwivedi, Shailendra; Gatalica, Zoran; Qian, Liangyue; Moxley, Katherine; Landrum, Lisa; Rowland, Michelle; Moor... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O012/#352 Atezolizumab and bevacizumab in recurrent endometrial cancer: a phase II, multi institutional trial. (4th December 2022) Authors: Fuh, Katherine; Richardson, Debra; Arend, Rebecca; Mccourt, Carolyn; Hagemann, Andrea; Liang, Margaret; Holman, Laura; Washington, Christina; Walker, Joan; Mannel, Robert; Youn, Grace; Mutch, David; Huh, Warner; Cohoon, Andrew; Iii, Charles Leath; Powell, Matthew; Gunderson-Jackson, Camille; Moor... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗